Loading company…
Maybio Matrix develops human extracellular matrix materials and products for regenerative medicine and medical aesthetics.
Founded in 2019 and based in Beijing, China, Maybio Matrix develops regenerative bioscaffold materials and products based on human extracellular matrix technology. Its products include collagen gels, fibers and solutions for medical devices, cosmetics and other applications. In April 2025, it closed Series A++ funding led by Cofoe, with participation from ZHONGGUANCUN SCIENCE-TECH LEASING CO., LTD.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in